However, our study failed to show any relationship between elevated CRP and our primary or secondary outcomes. In order to look further at the relationship of CRP with intracerebral hemorrhage, we evaluated the CAR, which has been used in predicting outcomes in a variety of illnesses (sepsis, small cell lung cancer, pancreatic cancer, etc) and has recently been found to be an independent risk factor of mortality in patients with traumatic brain injury and ischemic stroke [22,23]. The gene discussed is CRP; the disease is familial pancreatic carcinoma.